While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Pediatrics Repurposing Community that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of pediatric patients.
Our repurposing research and events within the Pediatrics Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Our efforts include finding and funding clinical repurposing projects to quickly impact pediatric patients in any disease area.
Funding Opportunity RFPs for Pediatrics:
CureAccelerator Live! for Pediatric Rare Diseases: up to $50,000 for a repurposing clinical trial in any pediatric rare disease. Winners selected at June 2021 event. Watch the full event and highlights video or read about the 4 finalists here.
As we develop and grow this Pediatric Community, we thank our early collaborative partner:
Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.
Real World Data Through a Patient’s Lens
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.
CureAccelerator Live! for Pediatric Rare Diseases 2021
Four finalists from institutions across the US and Chile competing for up to $50,000 to fund their repurposing clinical trials, all focused in pediatric rare diseases.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live! for Chicago 2020
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their repurposing clinical trials, including one for pediatrics. Read more about Dr. Lieber’s cerebral palsy project and watch him pitch it.
CureAccelerator Live! for Rare Diseases 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients, including two for pediatric oncology. Read more about Dr. Seif’s pediatric ALL project OR watch Dr. Sakamoto pitch her pediatric AML project.
CureAccelerator Live! for Rare Diseases 2019
Three finalists from the US and Italy competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients. Read more about Dr. Nichols pediatric HLH project.
CureAccelerator Live! for Oncology 2017
Five finalists from institutions across the US competing for up to $50,000 to fund their oncology repurposing clinical trials.
CureAccelerator Live! for Chicago 2016
Three finalists from Chicago-area institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.
Current Pediatric Research Projects
Completed Pediatric Research Projects
(in the past 3 years)